This suggests a possible upside of 93.1 from the stock's current price. On average, they expect RAPT Therapeutics' stock price to reach 60.17 in the next year. Their forecasts range from 49.00 to 72.00. Institutional investors and hedge funds own 89.49% of the company’s stock. Get the latest Rapt Therapeutics Inc (RAPT) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. 6 Wall Street analysts have issued 12 month target prices for RAPT Therapeutics' stock. Rhumbline Advisers now owns 13,199 shares of the company’s stock valued at $204,000 after acquiring an additional 2,415 shares during the last quarter. The price decrease on the next newsis expected to be -0.27 whereas the daily expected return is at this time at 0.32. The average volatility ofmedia hypeimpact on the company stock price is over 100. Finally, Rhumbline Advisers boosted its stake in Bolt Biotherapeutics by 22.4% in the second quarter. Rapt Therapeutics is projected to decline in value after the next headline with price expected to drop to 37.18. New York State Common Retirement Fund now owns 11,508 shares of the company’s stock valued at $178,000 after acquiring an additional 3,308 shares during the last quarter. New York State Common Retirement Fund boosted its stake in Bolt Biotherapeutics by 40.3% in the second quarter. This worrisome indicator is a canary in the coal mine for stock-market tops MarketWatch. Morgan Stanley purchased a new position in Bolt Biotherapeutics in the first quarter valued at about $156,000. California State Teachers Retirement System purchased a new position in Bolt Biotherapeutics in the first quarter valued at about $630,000. Royal Bank of Canada purchased a new position in Bolt Biotherapeutics during the first quarter worth about $39,000.
![rapt stock price rapt stock price](https://images-na.ssl-images-amazon.com/images/I/71dSi1cVRBL.jpg)
A number of other institutional investors have also recently added to or reduced their stakes in BOLT.